Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Karl Wilhelm Lauterbach

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Geographic Areas

Germany

Activities & Behaviors

Concepts & Ideas

Occupations

Evidence-Based Medicine

Disorders

Coronary Disease

Procedures

Objects

Hospitals

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
25
Gandjour, Afschin
16
Lüngen, Markus
10
Wendland, G
8
Schicha, Harald
8
Dietlein, Markus
7
Hinzpeter, B
7
Klever-Deichert, G
5
Moka, Detlef
5
Redaelli, Marcus
4
Baldamus, Conrad
4
Stock, Stephanie
4
Stoffel, Markus
3
Kurscheid, T
3
Troche, CJ
3
Kleinschmit, Frauke

Sign-in to see all Coauthors

Publications

TOP 3
Lüngen Markus; Schröer-Günther Milly-Anna; Passon Anna Marie; Gerber Andreas; Lauterbach Karl W
[Does the lack of evidence of effectiveness among international studies on interventions in prevention and health promotion have an impact on a German Act of Prevention?]
Stock Stephanie A K; Stollenwerk Björn; Redaelli Marcus; Civello Daniele; Lauterbach Karl W
Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
Gerber Andreas; Hentzelt Frieder; Lauterbach Karl W
Can evidence-based medicine implicitly rely on current concepts of disease or does it have to develop its own definition?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Karl Wilhelm Lauterbach (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lüngen Markus; Schröer-Günther Milly-Anna; Passon Anna Marie; Gerber Andreas; Lauterbach Karl W
[Does the lack of evidence of effectiveness among international studies on interventions in prevention and health promotion have an impact on a German Act of Prevention?]
Medizinische Klinik (Munich, Germany : 1983) 2009;104(2):101-7.
2008: Stock Stephanie A K; Stollenwerk Björn; Redaelli Marcus; Civello Daniele; Lauterbach Karl W
Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance.
Journal of women's health (2002) 2008;17(3):343-54.
2007: Gerber Andreas; Hentzelt Frieder; Lauterbach Karl W
Can evidence-based medicine implicitly rely on current concepts of disease or does it have to develop its own definition?
Journal of medical ethics 2007;33(7):394-9.
2007: Stock Stephanie Anja Katharina; Redaelli Marcus; Lauterbach Karl Wilhelm
Disease management and health care reforms in Germany - does more competition lead to less solidarity?
Health policy (Amsterdam, Netherlands) 2007;80(1):86-96.
2007: Stoffel Markus P; Haverkamp Heinz; Kromminga Arno; Lauterbach Karl W; Baldamus Conrad A
Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
Nephron. Clinical practice 2007;105(2):c90-8.
2006: Gerber A; Evers T; Haverkamp H; Lauterbach K W
Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction.
The European journal of health economics : HEPAC : health economics in prevention and care 2006;7(4):247-54.
2006: Stock Stephanie; Redaelli Marcus; Lauterbach Karl Wilhelm
The influence of the labor market on German health care reforms.
Health affairs (Project Hope) 2006;25(4):1143-52.
2006: Plamper E; Klever Deichert G; Lauterbach K W
[Effects of tobacco tax increase on cigarette consumption and the impact on health policy]
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2006;49(7):660-4.
2006: Stock S A K; Redaelli M; Wendland G; Civello D; Lauterbach K W
Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(3):299-305.
2005: Gandjour Afschin; Lauterbach Karl Wilhelm
[When is it worth reducing overuse of health care services? The example of prescribing expensive antihypertensives]
Medizinische Klinik (Munich, Germany : 1983) 2005;100(9):535-41.
2005: Gandjour Afschin; Lauterbach Karl Wilhelm
Does prevention save costs? Considering deferral of the expensive last year of life.
Journal of health economics 2005;24(4):715-24.
2005: Gandjour Afschin; Lauterbach Karl Wilhelm
How much does it cost to change the behavior of health professionals? A mathematical model and an application to academic detailing.
Medical decision making : an international journal of the Society for Medical Decision Making 2005;25(3):341-7.
2005: Gandjour Afschin; Telzerow Axel; Lauterbach Karl W;
European comparison of costs and quality in the treatment of acute back pain.
Spine 2005;30(8):969-75.
2005: Stock S; Redaelli M; Luengen M; Wendland G; Civello D; Lauterbach K W
Asthma: prevalence and cost of illness.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2005;25(1):47-53.
2005: Lauterbach K W; Gerber A; Klever-Deichert G; Stollenwerk B
[Cost-effectiveness of prevention of coronary disease in Germany]
Zeitschrift für Kardiologie 2005;94 Suppl 3():III/100-4.
2005: Gandjour Afschin; Kerschbaum Thomas; Reis Andreas; Lauterbach Karl Wilhelm
Technology assessment in dentistry: a comparison of the longevity and cost-effectiveness of inlays.
International journal of technology assessment in health care 2005;21(3):319-25.
2004: Gandjour A; Neumann I; Lauterbach K W
Appropriateness of invasive cardiovascular interventions in German hospitals (2000-2001): an evaluation using the RAND appropriateness criteria.
The Thoracic and cardiovascular surgeon 2004;52(6):365-71.
2004: Lüngen M; Stock S; Krauth C; Gerhardus A; Brandes I; Potthoff P; Müller U; Schmitz H; Klostermann B; Steinbach T; Schwartz F W; Lauterbach K W
[Performance and costs of outpatient clinics of university hospitals for medical care, teaching, research activities]
Deutsche medizinische Wochenschrift (1946) 2004;129(45):2399-404.
2004: Stoffel Markus P; Lauterbach Karl W; Baldamus Conrad A
[Guideline-based medical quality management in dialysis. Motivation and structuring of a quality-management system and integration of earlier disease stages of chronic renal failure]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2004;98(7):609-16.
2004: Stoffel M P; Barth C; Lauterbach K W; Baldamus C A
Evidence-based medical quality management in dialysis--Part II: Improvement of hemodialysis adequacy.
Clinical nephrology 2004;62(3):219-25.
2004: Stoffel M P; Barth C; Lauterbach K W; Baldamus C A
Evidence-based medical quality management in dialysis--Part I: Routine implementation of QiN, a German quality management system.
Clinical nephrology 2004;62(3):208-18.
2004: Lüngen Markus; Rupprecht Christoph J; Plamper Evelyn; Lauterbach Karl W
[Centralisation of breast cancer management by giving minimum work-load. Empirical effects in the region of North-Rhine, Germany]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2004;98(5):385-9.
2004: Gandjour Afschin; Telzerow Axel; Lauterbach Karl W;
Costs and quality in the treatment of acute depression in primary care: a comparison between England, Germany and Switzerland.
International clinical psychopharmacology 2004;19(4):201-8.
2004: Hauner H; Meier M; Wendland G; Kurscheid T; Lauterbach K; Study Group S A T;
Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2004;112(4):201-7.
2004: Gandjour Afschin; Lauterbach Karl Wilhelm
[At what time is a reduction of medical under- or overtreatment sensible? Treatment of acute depression as an example]
Psychiatrische Praxis 2004;31(3):157-62.
2004: Lüngen M; Lauterbach K W
[Health policy guidelines for ambulatory and brief inpatient surgery. Backgrounds, facts and possible future solutions]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2004;75(2):113-9.
2003: Gandjour Afschin; Lauterbach Karl Wilhelm
When is it worth introducing a quality improvement program? A mathematical model.
Medical decision making : an international journal of the Society for Medical Decision Making 2003;23(6):518-25.
2003: Lüngen M; Lauterbach K W
[Relevance of medical rehabilitation in disease management programmes]
Die Rehabilitation 2003;42(5):284-9.
2003: Gandjour Afschin; Bannenberg Angelika; Lauterbach Karl W
Threshold volumes associated with higher survival in health care: a systematic review.
Medical care 2003;41(10):1129-41.
2003: Gandjour Afschin; Neumann Iris; Lauterbach Karl Wilhelm
Appropriateness of invasive cardiovascular interventions in German hospitals (2000-2001): an evaluation using the RAND appropriateness criteria.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2003;24(4):571-7; discussion 577-8.
2003: Gandjour Afschin; Lauterbach Karl Wilhelm
Utilitarian theories reconsidered: common misconceptions, more recent developments, and health policy implications.
Health care analysis : HCA : journal of health philosophy and policy 2003;11(3):229-44.
2003: Heindel W; Datené S; Lauterbach K; Gandjour A
[Prospective observation of abdominal ultrasound in radiological emergency services: approaches to cost saving]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2003;175(9):1207-13.
2003: Lauterbach Karl W; Lüngen Markus
[DRG in the context of current health policy]
Medizinische Klinik (Munich, Germany : 1983) 2003;98(8):467-71.
2003: Gandjour Afschin; Lauterbach Karl Wilhelm
An evidence-based disease-management program for patients with diabetic nephropathy.
Journal of nephrology 2003;16(4):500-10.
2003: Gandjour Afschin; Lauterbach Karl W
The practice-makes-perfect hypothesis in the context of other production concepts in health care.
American journal of medical quality : the official journal of the American College of Medical Quality 2003;18(4):171-5.
2003: Zahn R; Fraiture B; Siegler K-E; Schneider S; Gitt A K; Seidl K; Gandjour A; Wendland G; Vogt S; Lauterbach K W; Senges J
Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center.
Zeitschrift für Kardiologie 2003;92(6):438-44.
2003: Lüngen M; Lauterbach K W
[Prospective payment in medical rehabilitation]
Die Rehabilitation 2003;42(3):136-42.
2003: Gandjour Afschin; Lauterbach Karl Wilhelm
Inductive reasoning in medicine: lessons from Carl Gustav Hempel's 'inductive-statistical' model.
Journal of evaluation in clinical practice 2003;9(2):161-9.
2003: Gandjour Afshin; Schlichtherle Stefanie; Neugebauer Antje; Rüssmann Walter; Lauterbach Karl Wilhelm
A cost-effectiveness model of screening strategies for amblyopia and risk factors and its application in a german setting.
Optometry and vision science : official publication of the American Academy of Optometry 2003;80(3):259-69.
2003: Krug B; Boettge M; Reineke T; Coburger S; Zähringer M; Harnischmacher U; Lüngen M; Lauterbach K W; Lehmacher W; Lackner K
[Quality control of outpatient imaging examinations in North Rhine-Westphalia, Part II]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2003;175(3):346-60.
2003: Krug B; Böttge M; Coburger S; Reineke T; Zähringer M; V Smekal U; Winnekendonk G; Harnischmacher U; Lüngen M; Lauterbach K W; Lehmacher W; Lackner K
[Quality control of outpatient imaging examinations in North Rhine-Westphalia, part I]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2003;175(1):46-57.
2002: Gandjour Afschin; Lauterbach Karl Wilhelm
[Cost-effectiveness of quality improvement measures in health care]
Medizinische Klinik (Munich, Germany : 1983) 2002;97(8):499-502.
2002: Gandjour A; Kleinschmit F; Lauterbach K W;
European comparison of costs and quality in the prevention of secondary complications in Type 2 diabetes mellitus (2000-2001).
Diabetic medicine : a journal of the British Diabetic Association 2002;19(7):594-601.
2002: Gandjour A; Kleinschmit F; Lauterbach K W;
European comparison of costs and quality in the treatment of acute myocardial infarction (2000-2001).
European heart journal 2002;23(11):858-68.
2002: Lauterbach K W; Evers T; Stock S
[Prevention and disease management of chronic diseases. Necessary and financial aspects]
Deutsche medizinische Wochenschrift (1946) 2002;127(22):1210-2.
2002: Lüngen Markus; Lauterbach Karl W
[Effectiveness of structural quality in quality assurance--a review]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2002;96(2):101-14.
2002: Lüngen Markus; Lauterbach Karl W
[Measuring case severity with a DRG-based reimbursement system]
Medizinische Klinik (Munich, Germany : 1983) 2002;97(2):70-6.
2002: Lüngen M; Lauterbach K W
[Result-oriented remuneration for hospital inpatient care]
Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)) 2002;64(1):46-53.
2002: Gloeckner Jennifer; Gandjour Afschin; Lauterbach Karl Wilhelm
A 'centres of excellence' approach in health care: points for and against.
Applied health economics and health policy 2002;1(3):120-2.
2002: Gandjour Afschin; Kleinschmit Frauke; Littmann Valerij; Lauterbach Karl Wilhelm
An evidence-based evaluation of quality and efficiency indicators.
Quality management in health care 2002;10(4):41-52.
2002: Wendland G; Klever-Deichert G; Lauterbach K
[Cost-effectiveness of coronary heart disease prevention]
Zeitschrift für Kardiologie 2002;91 Suppl 2():49-60.
2001: Wendland G; Klever-Deichert G; Lauterbach K
[Cost effectiveness of lipid lowering therapy]
Herz 2001;26(8):552-60.
2001: Lüngen M; Lauterbach K W
[Extent and causes of coding problems for total compensation on the basis of Diagnosis-Related Groups]
Deutsche medizinische Wochenschrift (1946) 2001;126(51-52):1449-53.
2001: Lüngen M; Lauterbach K W
[Does DRG improve or impair the quality of care?]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2001;72(10):suppl 270-3.
2001: Pfund A; Pütz J; Wendland G; Theisson M; Aydin U; Hinzpeter B; Lauterbach K; Pöhler E; Höpp H W
[Coronary intervention and occupational rehabilitation--a prospective, randomized intervention study]
Zeitschrift für Kardiologie 2001;90(9):655-60.
2001: Gandjour A; Lauterbach K W
[The relationship between provider volume and mortality rate: volume data of German centres of excellence]
Zeitschrift für Kardiologie 2001;90(9):613-20.
2001: Gandjour A; Lauterbach K W
[Development of an evidence-based questionnaire for evaluating the structural quality of providers]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2001;95(7):503-7.
2001: Gandjour A; Lauterbach K W
A method for assessing the cost-effectiveness and the break-even point of clinical practice guidelines.
International journal of technology assessment in health care 2001;17(4):503-16.
2000: Schlichtherle S; Gandjour A; Neugebauer A; Rüssmann W; Lauterbach K W
The cost-effectiveness of screening strategies for amblyopia: a preliminary report.
Strabismus 2000;8(4):291-5.
2000: Dietlein M; Weber K; Gandjour A; Moka D; Theissen P; Lauterbach K W; Schicha H
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.
European journal of nuclear medicine 2000;27(11):1598-609.
2000: Dietlein M; Weber K; Gandjour A; Moka D; Theissen P; Lauterbach K W; Schicha H
Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
European journal of nuclear medicine 2000;27(10):1441-56.
2000: Lüngen M; Lauterbach K W
[Applicability of diagnostic related groups (DRG) in an international comparison]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2000;71(10):1288-95.
2000: Hinzpeter B; Klever-Deichert G; Wendland G; Lauterbach K W
[Coronary disease and social security. A simulation model on cost analysis]
Herz 2000;25(5):515-25.
2000: Pfund A; Wendland G; Baer F; Lauterbach K; Höpp H W
[Stent implantation as initial coronary interventional therapy? A theoretical model on clinical and economical consequences of in-stent restenosis]
Herz 2000;25(5):495-501.
2000: Lüngen M; Lauterbach K W
[Upcoding--a risk for the use of diagnosis-related groups]
Deutsche medizinische Wochenschrift (1946) 2000;125(28-29):852-6.
2000: Klever-Deichert G; Hinzpeter B; Wendland G; Lauterbach K
[Cost-benefit analysis of an evidence-based secondary prevention of coronary heart diseases by statins. An analysis for Germany from a social security perspective]
Medizinische Klinik (Munich, Germany : 1983) 2000;95(6):305-13.
2000: Weber C; Lauterbach K W
[Pharmacoeconomy. Aspects of drug efficacy evaluation]
Der Internist 2000;41(4):349-54.
1999: Klever-Deichert G; Hinzpeter B; Hunsche E; Lauterbach K W
[Costs of coronary heart diseases over the remaining life time in coronary heart disease cases--an analysis of the current status of coronary heart disease cases in Germany from the social perspective]
Zeitschrift für Kardiologie 1999;88(12):991-1000.
1999: Steiner S; Lauterbach K W
[Development of evidence-based clinical practice guidelines; a model project integrating external evidence and clinical expertise]
Medizinische Klinik (Munich, Germany : 1983) 1999;94(11):643-7.
1999: Gandjour A; Lauterbach K W
Review of quality-of-life evaluations in patients with angina pectoris.
PharmacoEconomics 1999;16(2):141-52.
1999: Dietlein M; Knapp W H; Lauterbach K W; Schicha H
Economic evaluation studies in nuclear medicine: the need for standardization.
European journal of nuclear medicine 1999;26(6):663-80.
1999: Gandjour A; Lauterbach K W
[Allocation problems within the context of limited financial resources]
Der Internist 1999;40(3):255-9.
1999: Dietlein M; Scheidhauer K; Lauterbach K W; Schicha H
[Quality criteria for cost-benefit analysis in oncologic nuclear medicine and state of its realization]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 1999;93(1):49-55.
1999: Dietlein M; Moka D; Dederichs B; Hunsche E; Lauterbach K W; Schicha H
[Cost-effectiveness analysis: radioiodine or antithyroid medication in primary treatment of immune hyperthyroidism]
Nuklearmedizin. Nuclear medicine 1999;38(1):7-14.
1998: Kurscheid T; Lauterbach K
The cost implications of obesity for health care and society.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22 Suppl 1():S3-5; discussion S6.
1998: Berndt K; Hinzpeter B; Lauterbach K W
[The future of medical technology assessment in Germany--five proposals for its development]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 1998;92(6):401-5.
1998: Berndt K; Hinzpeter B; Kurscheid T; Lauterbach K W
[Conception and conversion of medical technology assessment--an international comparison]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 1998;92(4):255-62.
1998: Troche C J; Tacke J; Hinzpeter B; Danner M; Lauterbach K W
Cost-effectiveness of primary and secondary prevention in cardiovascular diseases.
European heart journal 1998;19 Suppl C():C59-65.
1998: Lauterbach K W
[Possibilities and limits of guidelines in medicine]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 1998;92(2):99-105.
1998: Dietlein M; Troche C J; Moka D; Bausch V; Lauterbach K W; Schicha H
[Consequences of new patient discharge guidelines on the cost structure of radioiodine therapy]
Nuklearmedizin. Nuclear medicine 1998;37(1):33-40.
1998: Dietlein M; Lauterbach K W; Schicha H
Treatment of toxic nodular goitres: Comparative costing of radioiodine therapy and surgery.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 1998;106 Suppl 4():S66-70.
1997: Dietlein M; Geckle L; Overbeck T; Moka D; Bausch V; Troche C J; Lauterbach K; Schicha H
[Cost minimization analysis for the definitive therapy of hyperthyroidism: comparison of goiter resection with radioiodine therapy]
Nuklearmedizin. Nuclear medicine 1997;36(5):150-6.
1997: Lauterbach K W; Lubecki P; Oesingmann U; Ollenschläger G; Richard S; Straub C
[A concept for a clearing procedure for guidelines in Germany]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 1997;91(3):283-8.

Sign-in to see more